Rewards Hub 21Shares has filed an application for a new INJ ETF, as disclosed by Injective on the X platform. The application was submitted on October 20, marking a significant step in expanding investment products related to the Injective Protocol.
21Shares Files for New INJ ETF
Disclaimer: The content provided on Phemex News is for informational purposes only. We do not guarantee the quality, accuracy, or completeness of the information sourced from third-party articles. The content on this page does not constitute financial or investment advice. We strongly encourage you to conduct you own research and consult with a qualified financial advisor before making any investment decisions.